Rhenman & Partners Asset Management’s Novo Nordisk NVO Stock Holding History

Rhenman & Partners Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-50,000	Closed	-$4.3M	–	98
2024 Q4	$4.3M	Sell	50,000 -50,000	-50%	-$5.41M	0.44%	58
2024 Q3	$11.9M	Buy	+100,000	New	+$13.3M	0.97%	35
2017 Q4	–	Sell	-160,000	Closed	-$3.85M	–	98
2017 Q3	$3.85M	Buy	+160,000	New	+$3.62M	0.49%	67

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Rhenman & Partners Asset Management's NVO Position: Q1 2025 in Review

Rhenman & Partners Asset Management sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 50,000 shares — an estimated $4.3M sold.

Rhenman & Partners Asset Management first reported a position in NVO in Q3 2017 and held it in 3 quarters. The position peaked at $11.9M in Q3 2024. 1,529 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

Rhenman & Partners Asset Management reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
Rhenman & Partners Asset Management sold 50,000 Novo Nordisk shares in Q1 2025, an estimated $4.3M.
Rhenman & Partners Asset Management first reported a position in Novo Nordisk in Q3 2017 and held it in 3 quarters.
Rhenman & Partners Asset Management's Novo Nordisk position peaked at $11.9M in Q3 2024.
1,529 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Rhenman & Partners Asset Management's 13F filing for Q1 2025, filed 14 May 2025.